The list of health conditions eligible for Connecticut’s medical marijuana program is expanding to 17, the Department of Consumer Protection said.
Following an April 22 decision by the medical marijuana program’s board of physicians, DCP will draft regulations to add Amyotrophic Lateral Sclerosis, Fabry disease and ulcerative colitis to the roster of eligible conditions.
Earlier this year, DCP said it would add sickle cell disease, severe psoriasis and psoriatic arthritis, and a type of post-surgical recurring back pain to the list.
Besides a vote by doctors, the process for adding conditions includes a public hearing and comment period, review by the state’s Attorney General, and a final vote from the legislature’s Regulation Review Committee.
Connecticut’s medical marijuana dispensaries began selling products in September.
